13F-HR filed by Avidity Partners Management LP
Avidity Partners Management LP filed this 13F-HR for the quarter ended 2023-06-30, filed 2023-08-14, with 93 holding rows worth $2,863,157,697.
- Accession
- 0001791827-23-000004
- Filer
- CIK 1791827
- Filed
- 2023-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2023
A holdings report, 93 entries on the cover page, a total value of $2,863,157,697 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,863,157,697 with VALUE read as dollars as filed, 13F file number 028-20028. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| BECTON DICKINSON & CO | 075887109 | COM | 398,050 | $105,089,181 | dollars as filed | |
| KARUNA THERAPEUTICS INC | 48576A100 | COM | 442,200 | $95,891,070 | dollars as filed | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 702,778 | $87,123,389 | dollars as filed | |
| GE HEALTHCARE TECHNOLOGIES INC COMMON STOCK | 36266G107 | Stock | 1,045,400 | $84,928,296 | dollars as filed | |
| TENET HEALTHCARE CORP COM NEW | 88033G407 | Stock | 990,500 | $80,606,890 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 184,300 | $71,827,239 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 2,985,700 | $70,163,950 | dollars as filed | |
| SURGERY PARTNERS INC | 86881A100 | COM | 1,555,000 | $69,959,450 | dollars as filed | |
| AbbVie,Inc. | 00287Y109 | COM | 518,400 | $69,844,032 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 2,773,189 | $68,830,551 | dollars as filed | |
| ZENTALIS PHARMACEUTICALS INC | 98943L107 | COMMON STOCK | 2,334,000 | $65,842,140 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 665,316 | $62,739,299 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 133,000 | $62,374,340 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 2,872,000 | $60,110,960 | dollars as filed | |
| UNIVERSAL HLTH SVCS INC CL B | 913903100 | Stock | 370,100 | $58,390,677 | dollars as filed | |
| BIO RAD LABS INC | 090572207 | CL A | 152,600 | $57,853,712 | dollars as filed | |
| CENCORA INC COM | 03073E105 | Stock | 300,000 | $57,729,000 | dollars as filed | |
| PACIFIC BIOSCIENCES CALIF INC COM | 69404D108 | Stock | 4,337,400 | $57,687,420 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 798,900 | $55,148,067 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 174,000 | $49,563,900 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 1,025,000 | $47,857,250 | dollars as filed | |
| CUREVAC N V | N2451R105 | COM | 4,300,000 | $44,806,000 | dollars as filed | |
| ACADIA HEALTHCARE COMPANY INC COM | 00404A109 | Stock | 550,000 | $43,802,000 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 875,000 | $43,697,500 | dollars as filed | |
| MCKESSON CORP COM | 58155Q103 | Stock | 101,200 | $43,243,772 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 468,700 | $42,698,570 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 785,700 | $42,498,513 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 900,700 | $41,549,291 | dollars as filed | |
| Pfizer Inc. | 717081103 | COM | 1,117,467 | $40,988,690 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 2,085,000 | $39,552,450 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 545,000 | $39,163,700 | dollars as filed | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 1,997,800 | $37,698,486 | dollars as filed | |
| ZOETIS INC CL A | 98978V103 | Stock | 217,000 | $37,369,570 | dollars as filed | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 535,000 | $36,529,800 | dollars as filed | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 1,425,000 | $34,955,250 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 575,000 | $34,477,000 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 297,500 | $34,069,700 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 925,000 | $32,985,500 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 1,325,000 | $31,694,000 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 1,075,000 | $28,756,250 | dollars as filed | |
| PRIVIA HEALTH GROUP INC | 74276R102 | COM | 1,079,806 | $28,193,735 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 1,949,700 | $27,919,704 | dollars as filed | |
| BAXTER INTL INC | 071813109 | COM | 604,700 | $27,550,132 | dollars as filed | |
| FUSION PHARMACEUTICALS INC | 36118A100 | COM | 5,700,000 | $26,619,000 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 1,326,000 | $26,347,620 | dollars as filed | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 415,000 | $26,228,000 | dollars as filed | |
| EDITAS MEDICINE INC | 28106W103 | COM | 3,000,000 | $24,690,000 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 692,500 | $22,714,000 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 432,900 | $21,064,914 | dollars as filed | |
| LANTHEUS HLDGS INC | 516544103 | COM | 245,100 | $20,568,792 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 400,000 | $20,400,000 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 954,500 | $20,178,130 | dollars as filed | |
| AMYLYX PHARMACEUTICALS INC | 03237H101 | COM | 901,400 | $19,443,198 | dollars as filed | |
| AXONICS INC | 05465P101 | COM | 379,700 | $19,163,459 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 481,300 | $18,530,050 | dollars as filed | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 24,800 | $17,819,792 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 1,687,500 | $17,010,000 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 916,600 | $16,608,792 | dollars as filed | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 878,600 | $16,473,750 | dollars as filed | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 395,855 | $16,142,967 | dollars as filed | |
| CEREVEL THERAPEUTICS HLDNG I | 15678U128 | COM | 501,200 | $15,933,148 | dollars as filed | |
| ACELYRIN INC | 00445A100 | COM | 750,000 | $15,675,000 | dollars as filed | |
| POINT BIOPHARMA GLOBAL INC | 730541109 | COM | 1,671,800 | $15,146,508 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 8,370,100 | $14,982,479 | dollars as filed | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 6,080,000 | $14,896,000 | dollars as filed | |
| SCHRODINGER INC COM | 80810D103 | Stock | 274,900 | $13,723,008 | dollars as filed | |
| 2SEVENTY BIO INC COMMON STOCK | 901384107 | Stock | 1,342,000 | $13,581,040 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 766,700 | $13,072,235 | dollars as filed | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 3,790,000 | $12,469,100 | dollars as filed | |
| CARIBOU BIOSCIENCES INC COM | 142038108 | Stock | 2,758,600 | $11,724,050 | dollars as filed | |
| NANOSTRING TECHNOLOGIES INC | 63009R109 | COM | 2,700,400 | $10,936,620 | dollars as filed | |
| ALPINE IMMUNE SCIENCES INC | 02083G100 | COM | 1,058,500 | $10,881,380 | dollars as filed | |
| INARI MED INC | 45332Y109 | COM | 175,000 | $10,174,500 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 526,376 | $9,974,825 | dollars as filed | |
| AC IMMUNE SA | H00263105 | SHS | 2,903,278 | $8,579,187 | dollars as filed | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 282,752 | $8,344,012 | dollars as filed | |
| COLLEGIUM PHARMACEUTICAL INC | 19459J104 | COM | 354,100 | $7,609,609 | dollars as filed | |
| ALPHATEC HLDGS INC | 02081G201 | COM NEW | 393,000 | $7,066,140 | dollars as filed | |
| AN2 THERAPEUTICS INC | 037326105 | COM | 657,200 | $5,586,200 | dollars as filed | |
| GRITSTONE BIO INC | 39868T105 | COM | 2,765,500 | $5,392,725 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 1,620,200 | $5,152,236 | dollars as filed | |
| SCYNEXIS INC | 811292200 | COM NEW | 1,738,734 | $5,129,265 | dollars as filed | |
| SYROS PHARMACEUTICALS INC | 87184Q206 | COM NEW | 1,464,034 | $4,611,707 | dollars as filed | |
| ALTIMMUNE INC | 02155H200 | COM NEW | 1,174,100 | $4,144,573 | dollars as filed | |
| CENTURY THERAPEUTICS INC | 15673T100 | COM | 1,110,900 | $3,510,444 | dollars as filed | |
| HYPERFINE INC | 44916K106 | Common Stock | 1,188,178 | $2,554,583 | dollars as filed | |
| SIMULATIONS PLUS INC | 829214105 | COM | 45,900 | $1,988,847 | dollars as filed | |
| CAREMAX INC | 14171W103 | COM | 636,000 | $1,977,960 | dollars as filed | |
| BAUSCH HEALTH COS INC COM | 071734107 | Stock | 215,100 | $1,720,800 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 37,800 | $1,571,346 | dollars as filed | |
| EXSCIENTIA PLC | 30223G102 | ADS | 127,600 | $755,392 | dollars as filed | |
| ARTERIS INC | 04302A104 | COM | 75,500 | $514,910 | dollars as filed | |
| NUVATION BIO INC | 67080N119 | WARR | 90,560 | $14,978 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001791827-23-000004 | this filing | 2023-08-14 | acceptance time not in the bulk data set |